Cancer Research UK Oxford Centre Members Prof Tim Maughan and Prof Gil McVean are among the eight medical researchers at Oxford University who have been elected as Fellows of the Academy of Medical Sciences. The honour recognises outstanding contribution to the advancement of medical science, innovative application of scientific knowledge, or conspicuous service to healthcare.
Professor Sir Robert Lechler PMedSci, President of the Academy of Medical Sciences said: ‘These new Fellows represent the amazing diversity of talent and expertise among the UK medical research community. Through their election to the Fellowship, we recognise the outstanding contributions these individuals have made to the progress of medical science and the development of better healthcare.
‘We work with our Fellowship to create the essential connections between academia, industry and the NHS and beyond, to strengthen biomedical research and facilitate its translation into benefits for society.’
The eight Oxford researchers elected are:
- Professor Timothy Maughan is Professor of Clinical Oncology and Deputy Director of the CRUK/MRC Oxford Institute for Radiation Oncology and the Cancer Research UK Oxford Centre Networking Lead. His research interests focus on the treatment of patients with colorectal cancer and he is involved in clinical trial design and execution in gastrointestinal cancers.
- Professor Gilean McVean is Professor of Statistical Genetics, Head of Bioinformatics and Statistical Genetics and Director of the Big Data Institute at Oxford University. His research covers several areas in the analysis of genetic variation, combining the development of methods for analysing high throughput sequencing data, theoretical work and empirical analysis.
- Professor Christopher Butler is Professor of Primary Care and Clinical Director of the University of Oxford Primary Care Clinical Trials Unit at Oxford University. His research focuses on common infections (especially the appropriate use of antibiotics and antibiotic resistance), and health behaviour change.
- Professor Georg Holländer is Hoffmann and Action Professor of Paediatrics and Head of the Department of Paediatrics at Oxford University. His research is interested in the development and function of the immune system in health and disease.
- Professor Sarah Lamb is Kadoorie Professor of Trauma Rehabilitation and Co-Director of the Oxford Clinical Trials Research Unit at Oxford University. Her research focuses on clinical trials and medical statistics, and she is Chief Investigator for a number of trials of rehabilitation interventions.
- Professor Martin Maiden is Professor of Molecular Epidemiology at Oxford University. His research studies the population biology and evolution of bacterial pathogens, with the objective of translating the insights obtained into benefits for human health.
- Professor Andrew Pollard is Professor of Paediatric Infection and Immunity, Director of the Oxford Vaccine Group and Honorary Consultant Paediatrician at Oxford University. His research interests focus on Current research activities include clinical trials of new and improved vaccines for children, invasive bacterial diseases in children in Nepal, studies of cellular and humoral immune responses to glycoconjugate vaccines, and development of a serogroup B meningococcal vaccine.
- Professor Elizabeth Robertson is Professor of Developmental Biology and Wellcome Trust Principal Research Fellow at Oxford University. Her research exploits mouse genetics to investigate the key signalling cues and transcriptional regulators governing cell fate decisions in the developing mammalian embryo.
The new Fellows will be formally admitted to the Academy at a ceremony on the 29th June 2016.